Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis - 06/09/18
Doi : 10.1016/j.jaci.2018.04.026
Dao X. Nguyen, BSc a, Alice Cotton, RN, BSc a, Laura Attipoe, MBBS a, Coziana Ciurtin, MBBS, PhD a, Caroline J. Doré, BSc b, Michael R. Ehrenstein, MBBS, PhD a 
a Division of Medicine, Centre for Rheumatology, University College London, London, United Kingdom
b Comprehensive Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, United Kingdom
| This work was funded by Arthritis Research UK (grant no. 20687) and the UCLH Biomedical Research Centre. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2018
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 3
P. 978 - septembre 2018 Retour au numéro
Article précédent
- Micro RNAs are required for Langerhans cell, skin- and lung-resident macrophage ontogeny
- Yi Yao, Carly Martin, Congcong Yin, Chunyuan Guo, Zheng Dong, Li Zhou, Qing-Sheng Mi
- Genetic variation in the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway affects contact hypersensitivity responses
- Julien M.D. Legrand, Edwige Roy, Batoul Baz, Pamela Mukhopadhyay, Ho Yi Wong, Ramesh Ram, Grant Morahan, Graeme Walker, Kiarash Khosrotehrani
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?